Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

David Lucchino joins AdvaMed board

This article was originally published in Clinica

Executive Summary

US industry association AdvaMed has elected David Lucchino, CEO of Semprus BioSciences, to its board of directors. Mr Lucchino will serve on AdvaMed's International Policy Committee, which aims to promote and improve access to medical technology in countries including Japan, Germany, France and the UK. He is also a member of the Emerging Company Issues subcommittee for AdvaMed's 2011 Medtech Conference, to be held in Washington, DC in September. AdvaMed is the world's largest trade association and represents around 400 medical device and diagnostics manufacturers. Cambridge, Massachusetts-based Semprus is a venture-funded spin-out of the Massachusetts Institute of Technology, which is developing a surface modification designed to reduce the attachment of particles such as bacteria and fungi to implanted medical devices.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT096881

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel